Riskpilot← Back to searchSign inGet full accessBIOTEST ApS
APSActiveCVR 26736994Svinøvej 39Technical testing and analysis · NACE 7120Est. 20021 employees
Revenue 2024
DKK 13K
-134% vs 2023
EBITDA margin
-259.8%
+46% vs 2023
Equity ratio
90.4%
Financial strength
Net profit 2024
DKK 101K
-58% vs 2023
| Revenue | DKK 13K | -134% |
| EBITDA | DKK -34K | +46% |
| Net profit | DKK 101K | -58% |
| Total assets | DKK 1,4M | -12% |
| Equity | DKK 1,2M | -2% |
| Employees | 1 | — |
Legal name
BIOTEST ApS
CVR number
26736994
Legal form
Anpartsselskab
NACE code
7120 · Technical testing and analysis
Founded
28. juni 2002
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive virksomhed med mikrobiologi, forskning, opbevaring og kontrol af mikroorganismer mv. samt integration af landbrugsaktiviteter i forbindelse med dyrknings- og fodringsforsøg, patentermv. og anden dermed beslægtet virksomhed
Address
Svinøvej 39
Phone
+4521776224
Email
pauli.kiel@bio-test.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 325 | -108 | 176 | 154 | 210 | -63 | -61 | 79 | 399 | 272 | -36 | -38 | 13 |
| Staff expenses | -25 | -50 | -156 | -145 | -145 | -69 | -39 | -116 | -282 | -452 | -67 | -25 | -47 |
| EBITDA | 300 | -158 | 20 | 9 | 65 | -133 | -100 | -38 | 118 | -180 | -103 | -63 | -34 |
| Depreciation & amort. | -19 | -19 | -15 | -12 | -12 | -12 | -12 | -6 | -2 | -0 | -0 | -0 | -0 |
| EBIT | 281 | -177 | 5 | -3 | 53 | -145 | -112 | -43 | 116 | -180 | -103 | -63 | -34 |
| Net financials | 225 | 280 | 92 | 374 | -197 | 244 | -49 | 399 | 244 | 343 | -287 | 269 | 162 |
| Profit before tax | 507 | 103 | 97 | 371 | -143 | 100 | -161 | 355 | 360 | 163 | -390 | 206 | 129 |
| Tax | 132 | 28 | 26 | 79 | -30 | 24 | -35 | 92 | 79 | 36 | 1 | -35 | 28 |
| Net profit | 374 | 75 | 71 | 292 | -113 | 75 | -126 | 263 | 280 | 127 | -391 | 241 | 101 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.750 | 1.699 | 1.697 | 2.044 | 1.746 | 1.636 | 1.395 | 1.625 | 1.863 | 1.950 | 1.436 | 1.560 | 1.367 |
| Equity | 1.408 | 1.392 | 1.464 | 1.656 | 1.442 | 1.414 | 1.182 | 1.337 | 1.507 | 1.521 | 1.016 | 1.257 | 1.236 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 342 | 307 | 233 | 388 | 304 | 223 | 213 | 288 | 356 | 429 | 420 | 303 | 131 |
| Total debt | 342 | 307 | 233 | 388 | 304 | 223 | 213 | 288 | 356 | 429 | 420 | 303 | 131 |
EBITDA margin
-259.8%
This company
15.8%
Market median
-1744% vs market
20122024
Equity ratio
90.4%
This company
38.2%
Market median
+137% vs market
20122024
Return on equity
8.2%
This company
18.4%
Market median
-55% vs market
20122024
Net profit margin
776.3%
This company
8.1%
Market median
+9484% vs market
20122024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20122024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2002 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOTEST ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|